Lori A. LaRosa

Changes in the Prevalence of Vancomycin‐Resistant Enterococci in Response to Antimicrobial Formulary Interventions: Impact of Progressive Restrictions on Use of Vancomycin and Third‐Generation Cephalosporins

Ebbing Lautenbach, Lori A. LaRosa, Ann Marie Marr et al. · Clinical Infectious Diseases · 2003 · 109 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Longitudinal Trends in Fluoroquinolone Resistance among Enterobacteriaceae Isolates from Inpatients and Outpatients, 1989–2000: Differences in the Emergence and Epidemiology of Resistance across Organisms

Ebbing Lautenbach, Brian L. Strom, Irving Nachamkin et al. · Clinical Infectious Diseases · 2004 · 103 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Comparison of Unit-Specific and Hospital-Wide Antibiograms Potential Implications for Selection of Empirical Antimicrobial Therapy

Shawn Binkley, Neil O. Fishman, Lori A. LaRosa et al. · Infection Control and Hospital Epidemiology · 2006 · 96 citations

Life Sciences, Microbiology, Antimicrobial Resistance +12

Fluoroquinolone Utilization in the Emergency Departments of Academic Medical Centers

Ebbing Lautenbach, Lori A. LaRosa, Nishaminy Kasbekar et al. · Archives of Internal Medicine · 2003 · 89 citations

Pharmacy, Emergency Medicine, Antimicrobial Pharmacotherapy +11

Evaluation of Antimicrobial Therapy Orders Circumventing an Antimicrobial Stewardship Program: Investigating the Strategy of “Stealth Dosing”

Lori A. LaRosa, Neil O. Fishman, Ebbing Lautenbach et al. · Infection Control and Hospital Epidemiology · 2007 · 55 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +17